4//SEC Filing
Puhlmann Markus 4
Accession 0000950170-25-033675
CIK 0000728387other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:29 PM ET
Size
30.9 KB
Accession
0000950170-25-033675
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2025-03-03+165,000→ 165,000 totalExercise: $2.46Exp: 2035-03-03→ Common Stock (165,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 13, 2025, with a grant date of March 3, 2025 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2025.
- [F2]Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
Perspective Therapeutics, Inc.
CIK 0000728387
Entity typeother
Related Parties
1- filerCIK 0001965071
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:29 PM ET
- Size
- 30.9 KB